Letteratura scientifica selezionata sul tema "Immunolog"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Immunolog".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Immunolog"
CASTA??EDA-ZARATE, S., E. GARCIAPROCEL, M. LOURDES-IRIGOYEN e L. P??REZ-TAMAYO. "Immunolog??ca del Halotano". Survey of Anesthesiology 29, n. 3 (giugno 1985): 161???162. http://dx.doi.org/10.1097/00132586-198506000-00017.
Testo completoОковитий, Сергій, Наталія Кондратюк e Єгор Поливанов. "РОЛЬ ГЛЮКУРОНОВОЇ КИСЛОТИ У БІОТРАНСФОРМАЦІЇ КСЕНОБІОТИКІВ: ХІМІЧНІ АСПЕКТИ". European Science, sge15-01 (30 dicembre 2019): 51–60. http://dx.doi.org/10.30890/2709-2313.2022-15-01-014.
Testo completoChica, Carmen. "Javier Sebasti�n Mazana Casanova: Historia de la immunolog�a". International Microbiology 6, n. 2 (1 giugno 2003): 153–54. http://dx.doi.org/10.1007/s10123-003-0126-z.
Testo completoRiechelmann, H., C. Bachert, O. Goldschmidt, B. Hauswald, L. Klimek, W. W. Schlenter, A. J. Tasman e M. Wagenmann. "Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege – Positionspapier der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (Sektion HNO) gemeinsam mit der Arbeitsgemeinschaft Klinische Immunolog". Allergologie 25, n. 09 (1 settembre 2002): 489–96. http://dx.doi.org/10.5414/alp25489.
Testo completoGhersetich, I. "Immunologic aspects: Immunology of mineral water spas". Clinics in Dermatology 14, n. 6 (dicembre 1996): 563–66. http://dx.doi.org/10.1016/s0738-081x(96)00085-5.
Testo completoHudspith, Barry. "Immunology and immunologic diseases of the lung". Food and Chemical Toxicology 28, n. 6 (gennaio 1990): 457. http://dx.doi.org/10.1016/0278-6915(90)90094-4.
Testo completoFaling, L. Jack. "Immunology and Immunologic Diseases of the Lung". JAMA: The Journal of the American Medical Association 262, n. 4 (28 luglio 1989): 570. http://dx.doi.org/10.1001/jama.1989.03430040142051.
Testo completoEL Hassouni, Youssef, Mohammed Bourhia, Ahmed Bari, Riaz Ullah, Hafiz Majid Mahmood, Syed Saeed Ali, Samir Ibenmoussa e Admou Brahim. "Evaluation of the performance of immunoblot and immunodot techniques used to identify autoantibodies in patients with autoimmune diseases". Open Chemistry 19, n. 1 (1 gennaio 2021): 237–44. http://dx.doi.org/10.1515/chem-2020-0101.
Testo completoCarbonara, A. "Dammacco F. (Ed.):Immunologia in Medicina (Immunology in Medicine)". La Ricerca in Clinica e in Laboratorio 19, n. 1 (dicembre 1989): 187–88. http://dx.doi.org/10.1007/bf02871808.
Testo completoDorian, Barbara, e Paul E. Garfinkel. "Stress, immunity and illness — a review". Psychological Medicine 17, n. 2 (maggio 1987): 393–407. http://dx.doi.org/10.1017/s0033291700024958.
Testo completoTesi sul tema "Immunolog"
Tjärnlund, Anna. "Mucosal Immunity in Mycobacterial infections". Doctoral thesis, Stockholm University, Wenner-Gren Institute for Experimental Biology, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-6782.
Testo completoMore than a century after the identification of the tubercle bacillus and the first attempts at vaccination, tuberculosis (TB) still remains one of the world’s most serious infectious diseases. TB, caused by the bacterium Mycobacterium tuberculosis, is typically a disease of the lung, which serves both as port of entry and as the major site of disease manifestation. The currently used vaccine, BCG, is administered parenterally and induces a systemic immune response. However, it fails to protect against pulmonary TB, thereby raising the question whether vaccination targeting the mucosal immunity in the lungs could be favourable.
The respiratory mucosal surfaces represent the first line of defence against a multitude of pathogens. Secretory IgA, in mucosal secretions has an important function by blocking entrance of pathogenic organisms and preventing infections. Additionally, a role for IgA in modulation of immune responses is currently being revealed. In this work, we investigated the relevance of mucosal IgA in protection against mycobacterial infections using mice deficient for IgA and the polymeric Ig receptor, the receptor responsible for mucosal secretions of IgA. Gene-targeted mice were more susceptible to mycobacterial infections in the respiratory tract and displayed reduced production of proinflammatory, and protective, factors such as IFN-γ and TNF-α in the lungs. The mechanisms explaining the defective proinflammatory responses in the lungs of deficient mice might involve impaired signalling through Fcα receptors, or homologous receptors, which could lead to inadequate activation of pulmonary macrophages. This could subsequently result in suboptimal induction and production of cytokines and chemokines important for attraction and migration of immune cells to the site of infection.
Induction of optimal adaptive immune responses to combat mycobacterial infections requires prompt innate immune activation. Toll-like receptors (TLRs) are vital components of the innate branch of the immune system, ensuring early recognition of invading pathogens. Using TLR-deficient mice we demonstrated an important role for TLR2, and partly TLR4, in protection against mycobacterial infection in the respiratory tract. TLR2-deficient mice failed to induce proper proinflammatory responses at the site of infection, and macrophages derived from the knockout mice displayed impaired anti-mycobacterial activity.
Experimental evidence has concluded that the immune response upon an infection can influence the outcome of succeeding infections with other pathogens. Concurrent infections might additionally interfere with responses to vaccinations and have deleterious effects. We developed an in vitro model to study the effect of a malaria infection on a successive M. tuberculosis infection. Our results demonstrate that a malaria blood-stage infection enhances the innate immune response to a subsequent M. tuberculosis infection with a Th1 prone profile. Reduced infectivity of malaria-exposed dendritic cells implies that a malaria infection could impose relative resistance to ensuing M. tuberculosis infection. However, a prolonged Th1 response may interfere with malaria parasite control.
The outcome of this work emphasizes the importance of generating effective immune responses in the local mucosal environment upon respiratory mycobacterial infections. It furthermore puts new light on the immunological interaction between parasites and mycobacteria, which could have implications for future vaccine research.
Vafa, Manijeh. "Human genetic factors in relation to Plasmodium falciparum infection". Licentiate thesis, Stockholm University, Wenner-Gren Institute for Experimental Biology, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-7136.
Testo completoIsraelsson, Elisabeth. "The role of antibody mediated parasite neutralization in protective immunity against malaria". Licentiate thesis, Stockholm University, Wenner-Gren Institute for Experimental Biology, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-7137.
Testo completoSjögren, Ylva. "Early infant gut flora and neutral oligosaccharides in colostrum in relation to allergy development in children". Licentiate thesis, Stockholm University, Wenner-Gren Institute for Experimental Biology, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-7152.
Testo completoToday, atopic allergy is the most common chronic disease among children in the developed world. The increase in allergy prevalence during the past decades in these countries might be associated with lower microbial exposure. The gut flora, consisting of approximately 800 different species of bacteria, has been postulated to be important for the development of a fully functional immune system. Essentially, these bacteria are in constant contact with the gut flora associated lymphoid tissue, the largest lymphoid tissue of the human body. Following birth, the sterile gut of the newborn is immediately colonised by various bacterial species. Actually, alterations in the infant gut flora have been associated with allergy development.
Human milk is the major food in infancy and could thus influence the composition of the infant gut flora. Immunomodulatory components in human milk might differ between mothers and could therefore explain the contradictory results seen regarding breastfeeding and allergy development. Oligosaccharides, the third most abundant solid component in human milk, survive the passage through the stomach and are utilised by the gut microbiota. We analysed nine abundant neutral oligosaccharides in colostrum samples from allergic and non-allergic women and related to subsequent allergy development in their children. We found a considerable variation in the concentration of neutral oligosaccharides in colostrum, which was not to be explained by the allergic status of the women. Neither was the consumption of neutral colostrum oligosaccharides related to the allergy development in children.
Relevant bacterial species in early faecal samples were analysed, with Real-time PCR, and related to allergy development in children followed up to five years of age. Infants who harboured Lactobacilli (L.) group I (L. rhamnosus, L. paracasei, L. casei) at 1 week of age and Bifidobacterium adolescentis at 1 month of age developed allergic disease less frequently during their first five years than infants who did not harbour these bacteria at the same time (p=0.004 and p=0.008 respectively).
In conclusion, the work presented in this thesis implies the importance of a diverse gut flora early in life for the development of a fully functional immune system. However, consumption of colostrum with high amounts of neutral oligosaccharides does not protect against early allergy development.
Ali, Magdi Mahmoud. "Immunologic aspects of the pathogenesis of human onchocerciasis". Doctoral thesis, Stockholm University, Wenner-Gren Institute for Experimental Biology, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-793.
Testo completoOnchocerciasis, or river blindness, is a parasitic disease that affects more than 20 million people globally. The induction of pathology is directly related to the presence and destruction of the microfilarial stages (mf) of this filarial nematode. The disease presents clinically with a wide spectrum of dermal and ocular manifestations, the basis of the variation is believed to involve the immune system. The clinical presentations of infected hosts relate to the intensity of the reactions against the parasite. Anti-microfilarial drugs are also thought to somehow involve the immune system in their pharmacological action. In this study we have investigated some of the factors that might contribute to the pathogenesis, with the aim of gaining a better understanding of the role of immune response in these host inflammatory reactions to Onchocerca volvulus parasite. In the first study we have highlighted the clinically most severe form of dermal onchocerciasis, known as reactive onchocercal dermatitis (ROD), one that is often ignored and has not been properly identified. This form has special characteristics and important biological information that could greatly assist the general understanding of the disease as a whole. Amongst the three major foci of the disease in the study country, Sudan, the prevalence of ROD was found to be associated with different environmental and epidemiological characteristics; strikingly higher in the hypo-endemic areas. Including ROD cases in the prevalence will upgrade the level of endemicity of a locality, and often bring patients much in need of treatment into mass treatment programs that currently only treat localities with medium to high levels of endemicity. In the following research studies, we tried to address the immunological characteristics of the clinically different onchocerciasis patients. Then we also investigated the role of genetic polymorphism in the gene encoding receptor that links innate and adaptive immunity, namely, FcγRIIa.
Patients with either of two major forms of the clinical spectrum-mild and severe dermatopathology were studied by assaying the antigen-driven proliferation of peripheral blood mononuclear cells and the ability of patients’ serum antibodies to promote cytoadherence activity to mf in vitro. Immune responses of those with severe skin disease were found to be stronger compared with the mild dermatopathology group. Mectizan® treatment was followed by an increase in immune responsiveness in those with initially poor responses. Thus the degree of dermatopathology is related to the host’s immune response against mf and immunocompetence may be necessary for Mectizan® to clear the infection efficiently.
The infection has also been associated with increased levels of circulating immune complexes (CIC) containing parasite antigens and a cytokine response that involves both pro-and anti-inflammatory cytokines. Our fourth paper investigated the effect of IC from the O. volvulus infected patients on the production of pro-and anti-inflammatory cytokines. CIC were increased in all patients studied. The precipitate from plasma treated with polyethylene glycol (PEG) were added to peripheral blood mononuclear cell (PBMC) cultures, and the levels of IL-10, tumor necrosis factor TNF-α, IL-1β and their endogenous antagonists soluble TNF-Rp75 and IL-1-receptor antagonist (IL-1ra) were measured. A significant induction of all cytokines measured occurred in the onchocerciasis patients compared to healthy controls. However, the IL-1ra level was suppressed. The suppression of the production of IL-1ra suggests that the IC containing antigens may have a selectively suppressive effect on the production of this anti-inflammatory cytokine; thus implicating its possible role in counteracting inflammatory responses associated with the disease, and suggesting a potential therapeutic significance.
FcgRIIa receptors are involved in many important biological responses, and considered as important mediators of inflammation. A polymorphism in the gene encoding this receptor, that is either arginine (R) or histidine (H) at position 131, affects the binding to the different IgG subclasses. We therefore hypothesized that this polymorphism might be one of the underlying mechanisms to the varied clinical presentations seen in this disease. FcgRIIa genotyping was carried out by gene specific polymerase chain reaction (PCR) and allele-specific restriction enzyme digestion of DNA from clinically characterized patients. The genotype R/R frequencies were found to be significantly higher among patients with the severe form of the disease (including ROD), and it was particularly associated with one tribe (Masaleet) compared to Fulani. Moreover, the H allele was found to be associated with lower risk of developing the severe form. As no significant difference was seen between onchocerciasis cases and controls, the study also implies that this polymorphism influences protection from developing the severe form rather than being related to protection from the infection.
Rahman, Muhammad Jubayer. "Diagnostic biomarkers and improved vaccination against mycobacterial infection". Licentiate thesis, Stockholm University, Wenner-Gren Institute for Experimental Biology, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-8238.
Testo completoTuberculosis (TB) remains one of the world’s most serious infectious diseases. It is estimated that a third of the world’s population is latently infected and 8 million new cases are recorded each year. Although BCG vaccination triggers protective immune responses in the neonates, it confers protection against only certain forms of childhood TB. Protection mediated by BCG, against pulmonary TB, is controversial as reported with variable efficacy ranging from 0-80%. In addition to the problems associated with the BCG vaccine, diagnosis of TB cannot be performed readily with the available tools. At present, an effective control of TB is highly dependent on the development of a new TB-vaccine as well as proper identification and treatment of individuals with active disease. Therefore, we particularly focused on identification of biomarker (s) of infection and the development of better vaccines, with special emphasis on the immune responses in the respiratory tract.
In the first study, we aimed to identify immune biomarker (s) of infection for better diagnosis of TB. Mice were infected with BCG administered i.n. or i.v., and the bacterial burden in the lungs, spleen and liver was examined. We measured IL-12, IFN-γ, TNF, soluble TNF receptors (sTNFR) and mycobacteria-specific antibodies in the broncho-alveolar lavage (BAL) and in serum in order to find immune correlates of infection. Results showed that sTNFR and mycobacteria-specific antibodies in BAL, but not in serum, might be useful in distinguishing active from latent infection or exposure to mycobacterial antigens.
In the second study, we investigated whether we could improve the currently used BCG vaccine. For this purpose, we tested a combination of neonatal vaccination protocol using BCG and posterior boosting with the protein heparin-binding hemagglutinin adhesion (HBHA). It has been described that immunization with native (n) HBHA but not recombinant (r) HBHA conferred protection against M. tuberculosis challenge in mice.
This protection was comparable to that afforded by the BCG vaccine. In order to improve the protective efficacy of the nHBHA vaccine we followed heterologous prime-boost strategy, comprising BCG vaccination at the neonatal age, followed by nHBHA boosting at the infant and adult ages. We also examined whether the rHBHA protein could boost BCG-mediated protective immunity. Cellular immune responses and protection as measured by control of bacterial growth in the lungs of the treated animals were followed. Our results showed an improved effect of BCG-priming on HBHA-immunization. The BCG/HBHA immunization protocol was more effective in induction of HBHA-specific immune responses, as well as in protection than when the animals received only BCG or HBHA alone. Importantly, our study revealed that nHBHA does not require co-administration with adjuvant provided that mice were primed with live BCG before boosting.
Finally, we hypothesized that in utero sensitization of the fetal immune system with nHBHA may improve nHBHA-specific immune responses after birth. The pregnant mother was immunized with nHBHA 1 week before delivery. After birth, the offspring received two doses (week 1 and week 4) of nHBHA formulated with cholera toxin. We examined HBHA-specific recall responses and protection after challenge with a high dose of BCG. We found that immune responses were improved by priming the pregnant mother, and that this also provided better protection than when the offspring received only BCG or HBHA neonatal vaccinations.
Sundström, Yvonne. "Phenotypic and functional studies of NK cells in neonates and during early childhood". Doctoral thesis, Stockholms universitet, Wenner-Grens institut för experimentell biologi, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-8258.
Testo completoWalldén, (Fredriksson) Jenny. "Studies of immunological risk factors in type 1 diabetes". Doctoral thesis, Linköpings universitet, Pediatrik, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-12441.
Testo completoAmoudruz, Petra. "Maternal immune characteristics and innate immune responses in the child in relation to allergic disease". Doctoral thesis, Stockholms universitet, Wenner-Grens institut, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-7818.
Testo completoSohlberg, Ebba. "Innate immune responses in cord blood,and the influence of pathological pregnancy". Licentiate thesis, Stockholms universitet, Avdelningen för immunologi, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-54575.
Testo completoLibri sul tema "Immunolog"
R, Green Douglas, a cura di. Immunology, a synthesis. 2a ed. Sunderland, Mass: Sinauer Associates, 1991.
Cerca il testo completoSchmetzer, Oliver. Basics Immunologie. München: Elsevier, Urban & Fischer, 2009.
Cerca il testo completoLuttmann, Werner. Der Experimentator: Immunologie. 3a ed. Heidelberg: Spektrum Akademischer Verlag, 2009.
Cerca il testo completo1942-, Daniele Ronald P., a cura di. Immunology and immunologic diseases of the lung. Boston: Blackwell Scientific Publications, 1988.
Cerca il testo completo1934-, Bellanti Joseph A., a cura di. Immunology III. Philadelphia: Saunders, 1985.
Cerca il testo completoHeddy, Zola, a cura di. Laboratory methods in immunology. Boca Raton, Fla: CRC Press, 1990.
Cerca il testo completoM, Weir D., a cura di. Handbook of experimental immunology. 4a ed. Oxford [Oxfordshire]: Blackwell Scientific Pub., 1986.
Cerca il testo completo1920-2008, Dixon Frank J., e Alt Frederik, a cura di. Advances in immunology. San Diego: Academic Press, 2000.
Cerca il testo completo1920-2008, Dixon Frank J., a cura di. Advances in immunology. New-York: Academic Press, 1998.
Cerca il testo completo1920-, Dixon Frank J., a cura di. Advances in immunology. San Diego: Academic Press, 1998.
Cerca il testo completoCapitoli di libri sul tema "Immunolog"
Allen, Herbert B. "Immunology". In The Etiology of Atopic Dermatitis, 35–42. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6545-3_4.
Testo completoSabel, Michael Scott. "Immunology". In Dermatological Cryosurgery and Cryotherapy, 47–59. London: Springer London, 2016. http://dx.doi.org/10.1007/978-1-4471-6765-5_7.
Testo completoMcGrew, Roderick E. "Immunology". In Encyclopedia of Medical History, 146–59. London: Palgrave Macmillan UK, 1985. http://dx.doi.org/10.1007/978-1-349-05429-9_8.
Testo completoChapel, Helen. "Immunology". In Fetal and Neonatal Pathology, 249–63. London: Springer London, 1987. http://dx.doi.org/10.1007/978-1-4471-3523-4_13.
Testo completoRayner, Hugh, Mark Thomas e David Milford. "Immunology". In Understanding Kidney Diseases, 197–214. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-23458-8_14.
Testo completoNahler, Gerhard. "immunology". In Dictionary of Pharmaceutical Medicine, 89. Vienna: Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-89836-9_669.
Testo completoBuchheim, Judith-Irina, Brian Crucian e Alexander Choukèr. "Immunology". In Encyclopedia of Bioastronautics, 1–8. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-10152-1_23-1.
Testo completoBuchheim, Judith-Irina, Brian Crucian e Alexander Choukèr. "Immunology". In Handbook of Bioastronautics, 1–8. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-10152-1_23-2.
Testo completoModrow, Susanne, Dietrich Falke, Uwe Truyen e Hermann Schätzl. "Immunology". In Molecular Virology, 69–94. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-20718-1_7.
Testo completoHelvacioglu, A. "Immunology". In New Trends in Reproductive Medicine, 134–41. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-60961-9_13.
Testo completoAtti di convegni sul tema "Immunolog"
Zhang, Ping, Lou Chitkushev, Vladimir Brusic e Guang Lan Zhang. "Biomarkers in Immunology". In BCB'13: ACM-BCB2013. New York, NY, USA: ACM, 2013. http://dx.doi.org/10.1145/2506583.2512358.
Testo completoWenzel, Gentiana I., Silke Wemmert, Tina Schmidt, Sabine Heine, Alessandro Bozzato, Arne Simon, Martina Sester e Bernhard Schick. "Cholesteatoma, immunology and gender medicine". In 95th Annual Meeting German Society of Oto-Rhino-Laryngology, Head and Neck Surgery e. V., Bonn. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1785024.
Testo completoClements, Patrick, Jeremy Pesner e Jeremiah Shepherd. "The teaching of immunology using educational". In the 47th Annual Southeast Regional Conference. New York, New York, USA: ACM Press, 2009. http://dx.doi.org/10.1145/1566445.1566474.
Testo completoAdnan, NurHidayah, Yuzita Yaacob, Mohammad Khatim Hassan, Hamzah Mohd Salleh e Ibrahim Ali Noorbatcha. "Developing CAS models in immunology teaching". In 2009 International Conference on Electrical Engineering and Informatics (ICEEI). IEEE, 2009. http://dx.doi.org/10.1109/iceei.2009.5254798.
Testo completoTheis, F. J., D. Hartl, S. Krauss-Etschmann e E. W. Lang. "Neural network signal analysis in immunology". In Seventh International Symposium on Signal Processing and Its Applications, 2003. Proceedings. IEEE, 2003. http://dx.doi.org/10.1109/isspa.2003.1224857.
Testo completoMakki, I., e B. Bangash. "Immunologic Therapy Induced Asthma". In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1377.
Testo completoHANG, XIAOSHU, e HONGHUA DAI. "IMMUNOLOGY-BASED SUBSPACE DETECTORS FOR ANOMALY DETECTION". In Proceedings of the International Conference. WORLD SCIENTIFIC, 2008. http://dx.doi.org/10.1142/9789812819079_0030.
Testo completoBeverland, Andrew. "IMMUNOLOGY FOR A SPIRALLED UNDERGRADUATE MEDICAL CURRICULUM". In 14th annual International Conference of Education, Research and Innovation. IATED, 2021. http://dx.doi.org/10.21125/iceri.2021.2176.
Testo completoWen, Chen, Li Tao, Shi Yuanquan e Fu Yanming. "A Worm Detection Model Based on Artificial Immunology". In 2009 Third International Symposium on Intelligent Information Technology Application. IEEE, 2009. http://dx.doi.org/10.1109/iita.2009.112.
Testo completoDunn, Patrick J., Elizabeth Thomson, John Campbell, Thomas Smith, Vincent Desborough, Jeffrey Wiser, Henry Schaefer et al. "ImmPort: Shared research data for bioinformatics and immunology". In 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2015. http://dx.doi.org/10.1109/bibm.2015.7359752.
Testo completoRapporti di organizzazioni sul tema "Immunolog"
Beltyukov, E. K., V. V. Naumova e O. G. Smolenskaya. Clinical immunology. SIB-Expertise, febbraio 2023. http://dx.doi.org/10.12731/er0675.21022023.
Testo completoYusim, Karina, Bette Tina Korber, Christian Brander, Dan Barouch, Rob de Boer, Barton F. Haynes, Richard Koup, John P. Moore, Bruce D. Walker e David Watkins. HIV Molecular Immunology 2015. Office of Scientific and Technical Information (OSTI), aprile 2016. http://dx.doi.org/10.2172/1248095.
Testo completoYusim, Karina, Bette Tina Marie Korber, Dan Barouch, Richard Koup, Rob de Boer, John P. Moore, Christian Brander, Barton F. Haynes e Bruce D. Walker. HIV Molecular Immunology 2014. Office of Scientific and Technical Information (OSTI), febbraio 2015. http://dx.doi.org/10.2172/1169681.
Testo completoLitusov, N. V., e D. A. Proschenko. General immunology. Electronic training manual. SIB-Expertise, luglio 2022. http://dx.doi.org/10.12731/er0581.29072022.
Testo completoSergeev, Alexander, Nikolay Litusov, Ekaterina Voroshilina, Alexey Kozlov, Yulia Grigoryeva, Danila Zornikov, Vasily Petrov et al. Electronic educational resource Microbiology, virology and immunology. SIB-Expertise, gennaio 2024. http://dx.doi.org/10.12731/er0769.29012024.
Testo completoCortés Ortigosa, Francisco, e María Pascual Mora. Characterization of the extraction method of extracellular vesicles by HDL and LDL contamination. Fundación Avanza, maggio 2023. http://dx.doi.org/10.60096/fundacionavanza/2902022.
Testo completoLee, Peter P. Immunology, Systems Biology, and Immunotherapy of Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, marzo 2008. http://dx.doi.org/10.21236/ada485652.
Testo completoLee, Peter P. Immunology, Systems Biology, and Immunotherapy of Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, marzo 2010. http://dx.doi.org/10.21236/ada532381.
Testo completoLee, Peter P. Immunology, Systems Biology, and Immunotherapy of Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, marzo 2009. http://dx.doi.org/10.21236/ada505203.
Testo completoMarceau, Carla, Matthew Stillerman, Maureen Stiliman e Stephanie Forrest. Computational Immunology for the Defense of Large Scale Systems. Fort Belvoir, VA: Defense Technical Information Center, luglio 2002. http://dx.doi.org/10.21236/ada407600.
Testo completo